Clinical failure among children with nonsevere community-acquired pneumonia treated with amoxicillin

Bibliography

• McIntosh K. Current concepts: community-acquired pneumonia in children. N Engl J Med 2002;346:429-37
   PubMed Web of Science ®Google Scholar
• Benguigui Y, Stein F. Integrated management of childhood illness: an emphasis on the management of infectious diseases. Semin Pediatr Infect Dis 2006;17:80-98
   PubMedGoogle Scholar
• McCracken GH Jr. Etiology and treatment of pneumonia. Pediatr Infect Dis J 2000;19:373-7
   PubMed Web of Science ®Google Scholar
• Shan F. The management of pneumonia in children in developing countries. Clin Infect Dis 1995;21(Suppl 3):S218-15
   PubMedGoogle Scholar
• Nascimento-Carvalho CM, Lopes AA, Gomes MD, The burden of pneumonia among children. J Trop Pediatr 2001;47:253-4
   PubMed Web of Science ®Google Scholar
• Grant GB, Campbell H, Dowell SF, Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis 2009;9:185-96
   PubMed Web of Science ®Google Scholar
• Nascimento-Carvalho CM. Etiology of childhood community acquired pneumonia and its implications for vaccination. Braz J Infect Dis 2001;5:87-97
   PubMedGoogle Scholar
• Nascimento-Carvalho CM. Pharmacotherapy of childhood pneumonia. Expert Opin Pharmacother 2010;11:225-31
   PubMed Web of Science ®Google Scholar
• Jacobs MR. Antimicrobial-resistant Streptococcus pneumoniae: trends and management. Expert Rev Anti Infect Ther 2008;6:619-35
   PubMed Web of Science ®Google Scholar
• El-Radhi AS, Barry W. Thermometry in paediatric practice. Arch Dis Child 2006;91:351-6
   PubMed Web of Science ®Google Scholar
• World Health Organization. Integrated management of childhood illness chart booklet. WC 503.2. Geneva: WHO; 2008. Available from: http://whqlibdoc.who.int/publications/2008/9789241597289_eng.pdf [Last accessed 15 January 2009]
   Google Scholar
• Nascimento-Carvalho CM, Souza-Marques HH. Recommendation of the Brazilian Society of Pediatrics for antibiotic therapy in children and adolescents with community-acquired pneumonia. Pan Am J Public Health 2004;15:380-7
   Web of Science ®Google Scholar
• Ayieko P, English M. Case management of childhood pneumonia in developing countries. Pediatr Infect Dis J 2007;26:432-40
   PubMed Web of Science ®Google Scholar
• Cherian T, Mulholland EK, Carlin JB, Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ 2005;83:353-9
   PubMed Web of Science ®Google Scholar
• Straus WL, Qazi SA, Kundi Z, Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxicillin for pneumonia among children in Pakistan: randomized controlled trial. Pakistan Co-trimoxazole Study Group. Lancet 1998;352:270-4
   PubMed Web of Science ®Google Scholar
• Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 2002;360:835-41
   PubMed Web of Science ®Google Scholar
• Agarwal G, Awasthi S, Kabra SK, Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled Trial. BMJ 2004;328:791-6
   PubMed Web of Science ®Google Scholar
• Hazir T, Qazi SA, Bin Nisar Y, Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2 – 59 months: a multi-centre, double blind, randomised controlled trial in Pakistan. Arch Dis Child 2007;92:291-7
   PubMed Web of Science ®Google Scholar
• Awasthi S, Agarwal G, Singh JV, Effectiveness of 3-day amoxycillin vs 5-day co-trimoxazole in the treatment of non-severe pneumonia in children aged 2 – 59 months of age: a multi-centric open labeled trial. J Trop Pediatr 2008;54:382-9
   PubMed Web of Science ®Google Scholar
• Awasthi S, Agarwal G, Kabra SK, Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial. PLoS One 2008;3:e1991
   PubMed Web of Science ®Google Scholar
• Korppi M. Community-acquired pneumonia in children: issues in optimizing antibacterial treatment. Paediatr Drugs 2003;5:821-32
   PubMedGoogle Scholar
• Dimopoulos G, Matthaiou DK, Karageorgopoulos DE, Short- versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis. Drugs 2008;68:1841-54
   PubMed Web of Science ®Google Scholar
• Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Databse Syst Rev 2008;2:CD005976
   Google Scholar
• Council for International Organisations of Medical Sciences. Current challenges in pharmacovigilance: pragmatic approaches: report of CIOMS working group V. Geneva: CIOMS; 2001
   Google Scholar
• Virkki R, Juven T, Mertsola J, Ruuskanen O. Radiographic follow-up of pneumonia in children. Pediatr Pulmonol 2005;40:223-7
   PubMed Web of Science ®Google Scholar
• Nascimento-Carvalho CM, Ribeiro CT, Cardoso MR, The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis 2008;27:939-41
   Google Scholar
• Wolkers PC, Mantese OC, de Paula A, New susceptibility breakpoints in antimicrobial resistance rates of invasive pneumococcal strains. J Pediatr (Rio J) 2009;85:421-5
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Reed MD. Variations in amoxicillin pharmacokinetic/pharmacodynamic parameters may explain treatment failures in acute otitis media. Paediatr Drugs 2009;11:243-9
   PubMedGoogle Scholar